The New York Entrepreneur

Eli Lilly’s weight loss drug slashes the risk of developing diabetes in long-term trial

Read Time:6 Second

The late-stage trial on tirzepatide also found that patients experienced sustained weight loss over the roughly three-year treatment period.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Lowe’s cuts full-year outlook as it expects home improvement sales to weaken
Next post Lowe’s cuts full-year outlook as it expects home improvement sales to weaken